Pharmacogenomics; research and development of the pharmacogenomics, the policy development for pharmacogenomics test, social perspective and health economic evaluation of pharmacogenomic tests.
The determination of genetic risks of complex traits and implication of these information for improving health in populations.
Application Development for the genetic epidemiology analysis,
focus on the biological driven analysis.